Announcement
20 Feb 2026
In February 2026, the European Commission committed a total of EUR 225 million for the development and clinical advancement of next-generation influenza vaccines through a pre-commercial procurement scheme under the EU4Health programme.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
20 Feb 2026
Revocation date:
No revocation date
Updated: 20 Feb 2026
Public procurement, nes
In force
Recent update from 20 Feb 2026:
On 20 February 2026, the European Commission committed a total of EUR 225 million (USD 264.7 million) in funding to facilitate the development and clinical testing of next-generation influenza vacc...
Sign in to see more
Threads
See all
This state act is not part of any Thread yet.